The Role of Real-World Evidence in the Price and Reimbursement Decisions for Rare Diseases... 02/04/2024 Healthcare Rare diseases Innovative drugs Financing Real-world evidence (RWE) is a promising source of data that could help to accelerate drug access in rare diseases. Partners
The city of Vigo will host the next edition of "Galicia Biodays" on June 12 and 13 01/04/2024 Healthcare International Financing Talento On June 12 and 13, Vigo will become the capital of biotechnology for the celebration of the II edition of "Galicia... Partners - BIOGA
Celtarys Research, USC-biofarma and ZeClinics seek new therapeutic targets for Parkinson's... 01/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Advanced therapies This project, coordinated by Asebio, brings together ZeClinics' target validation and in vivo drug screening... AseBio
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary therapy agains... 25/03/2024 Healthcare Advanced therapies A public-private consortium, led by the Spanish biotech company Hemostatics, located in the Barcelona Science Park, and... Partners - Parc Científic de Barcelona
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
Sustainable agriculture, new food sources, protection against infectious diseases or waste... 26/03/2024 Healthcare Biosimilars Rare diseases Climate change Agrifood Food & feed Agriculture Biotechnology provides solutions through plant genetic engineering, the revaluation of food industry by-products, new... AseBio
Sustainable agriculture, new food sources, protection against infectious diseases or waste... 25/03/2024 Humanity is at a critical moment for its future, with the need to promote more sustainable economic models that respond... AseBio
The European Virtual Biotechnology Forum: Next Generation Sequencing Advancements and Ris... Online Del 03/04/2024 15:00 to 03/04/2024 17:10 Healthcare Access to innovation International Digitalization The European Biotechnology Forum: Next Generation Sequencing Advancements and Risks: Next-Generation-Sequencing (NGS)...
Spanish biotechnology leads the global fight against tuberculosis 24/03/2024 Healthcare Access to innovation Innovative drugs On the occasion of World Tuberculosis Day, we delve into the advances achieved by the candidate vaccine against... AseBio - Zendal
Konexio Biotech, in the First Day of Inspection and Control of Medicines AEMPS & AEFI 22/03/2024 Healthcare Drug discovery Innovative drugs This Thursday, March 21, Konexio Biotech, represented by its CEO, Andrea Romero, participated in the 'First Day of... Partners - KONEXIO BIOTECH
